Using films as a psychoeducation tool for patients with schizophrenia: a pilot study using a quasi-experimental pre-post design

BMC Psychiatry

Christine Rummel-Kluge²  Wolfgang Schreiber⁴  Werner Kissling¹  Frauke Görges³  Christian von Maffei³ 

[1] Department of Psychiatry and Psychotherapy, Technische Universität München, Möhlstr. 26, München, 81675, Germany;Forschungszentrum Depression der Stiftung Deutsche Depressionshilfe, Semmelweisstr. 10, Leipzig, 04103, Germany;Department of Psychiatry and Psychotherapy, University of Leipzig, Semmelweisstr. 10, Leipzig, D-04103, Germany;Bezirksklinikum Mainkofen, Deggendorf, 94469, Germany

关键词: Group;    Film;    Psychoeducation;    Schizophrenia;   

Others  :  1178990
DOI  :  10.1186/s12888-015-0481-2

 received in 2014-11-20, accepted in 2015-04-23,  发布年份 2015

【 摘 要 】

Background

Relapses and, subsequently, readmissions are common in patients with schizophrenia. Psychoeducation has been shown to reduce the number and duration of readmissions. Yet, only little more than 20% of psychiatric patients in German speaking countries receive psychoeducation. Among other reasons, costs may be considered too high by hospitals. The objective of the present study was to test the feasibility of a new cost-efficient approach in the psychoeducation of patients with schizophrenia. In this study, films were used to impart knowledge about the illness to inpatients.

Methods

A total of 113 participants were initially included in the study, eleven of which were not included in the final analyses. Six films about the symptoms, diagnosis, causes, warning signs, treatment of schizophrenia and about the influence of family members and friends were shown in a group setting in the presence of nursing staff. All films combined facts, expert opinions, and personal experiences of peers. As the main outcome criterion of this feasibility pilot study, we measured the effects on knowledge. Secondary outcome measures included compliance, insight into illness, side effects, and quality of life. Data were collected directly after the intervention and about half a year afterwards. The number and the duration of readmissions to the hospital were recorded and compared to the number and duration of prior admissions. Patients were also asked to state their subjective opinion about the films. Main data analyses were done using paired t-tests and Wilcoxon signed-rank tests. Secondary analyses also involved ANOVAs and ANCOVAs.

Results

One hundred and two inpatients were included in the data analyses. Showing the films in the tested setting was shown to be feasible. Knowledge about schizophrenia (p < .001), compliance (ps < .01), insight into illness (p < .01), and quality of life (p < .001) all increased significantly after patients had watched the films and remained stable for at least half a year. A vast majority (84.9%) of the patients found the films to be interesting and informative.

Conclusions

Using films to educate inpatients about schizophrenia is a feasible method that is cost- and time-efficient and well received by the patients.

【 授权许可】

   
2015 von Maffei et al.; licensee BioMed Central.

【 参考文献 】

• [1]Schooler NR: Relapse and rehospitalization: comparing oral and depot antipsychotics. J Clin Psychiatry 2003, 64(Suppl 16):14-17.
• [2]Kissling W, Leucht S: Results of treatment of schizophrenia: is the glass half full or half empty? Int Clin Psychopharmacol 1999, 14(Suppl 3):S11-S14.
• [3]Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV: Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 2002, 63:892-909.
• [4]Jeffreys SE, Harvey CA, McNaught AS, Quayle AS, King MB, Bird AS: The Hampstead Schizophrenia Survey 1991. I: Prevalence and service use comparisons in an inner London health authority, 1986–1991. Br J Psychiatry 1997, 170:301-306.
• [5]Weiden P, Glazer W: Assessment and treatment selection for "revolving door" inpatients with schizophrenia. Psychiatr Q 1997, 68:377-392.
• [6]Gilmer TP, Dolder CR, Lacro JP, Folsom DP, Lindamer L, Garcia P, et al.: Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am J Psychiatry 2004, 161:692-699.
• [7]Rummel-Kluge C, Schuster T, Peters S, Kissling W: Partial compliance with antipsychotic medication is common in patients with schizophrenia. Aust N Z J Psychiatry 2008, 42:382-388.
• [8]Gibson S, Brand SL, Burt S, Boden ZVR, Benson O: Understanding treatment non-adherence in schizophrenia and bipolar disorder: a survey of what service users do and why. BMC Psychiatry 2013, 13:153. BioMed Central Full Text
• [9]Rettenbacher MA, Hofer A, Eder U, Hummer M, Kemmler G, Weiss EM, et al.: Compliance in schizophrenia: psychopathology, side effects, and patients' attitudes toward the illness and medication. J Clin Psychiatry 2004, 65:1211-1218.
• [10]Fenton WS, Blyler CR, Heinssen RK: Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull 1997, 23:637-651.
• [11]Anselmetti S, Bechi M, Bosia M, Quarticelli C, Ermoli E, Smeraldi E, et al.: ‘Theory’of mind impairment in patients affected by schizophrenia and in their parents. Schizophr Res 2009, 115:278-285.
• [12]Nuechterlein KH, Ventura J, Subotnik KL, Bartzokis G: The early longitudinal course of cognitive deficits in schizophrenia. J Clin Psychiatry 2014, 75:25.
• [13]Thieda P, Beard S, Richter A, Kane J: An economic review of compliance with medication therapy in the treatment of schizophrenia. Psychiatr Serv 2003, 54:508-516.
• [14]Weiden PJ, Olfson M: Cost of relapse in schizophrenia. Schizophr Bull 1995, 21:419-429.
• [15]Nose M, Barbui C, Gray R, Tansella M: Clinical interventions for treatment non-adherence in psychosis: meta-analysis. Br J Psychiatry 2003, 183:197-206.
• [16]Bauml J, Frobose T, Kraemer S, Rentrop M, Pitschel-Walz G: Psychoeducation: a basic psychotherapeutic intervention for patients with schizophrenia and their families. Schizophr Bull 2006, 32(Suppl 1):S1-S9.
• [17]Rummel-Kluge C, Pitschel-Walz G, Kissling W: A fast, implementable psychoeducation program for schizophrenia. Psychiatr Serv 2007, 58:1226.
• [18]Pekkala E, Merinder L. Psychoeducation for schizophrenia. Cochrane Database Syst Rev. 2011;15(6):CD002831.
• [19]Pitschel-Walz G. Die Einbeziehung der Angehörigen in die Behandlung schizophrener Patienten und ihr Einfluss auf den Krankheitsverlauf. In: Lang P, editor. [Europäische Hochschulschriften. Reihe VI, Psychologie Publications universitaires européennes. Série VI, Psychologie European university studies. Series VI, Psychology, vol. 581], vol. 19. Frankfurt am Main, New York; 1997. p. 99–118.
• [20]Xia J, Merinder LB, Belgamwar MR. Psychoeducation for schizophrenia. Cochrane Database Syst Rev. 2011.15;(6):CD002831.
• [21]Pitschel-Walz G, Bauml J, Bender W, Engel RR, Wagner M, Kissling W: Psychoeducation and compliance in the treatment of schizophrenia: results of the Munich psychosis information project study. J Clin Psychiatry 2006, 67:443-452.
• [22]Pitschel Walz G, Boerner R, Mayer CER, Peuker I, Welschehold M, Bender W, et al.: Informationszentrierte gruppen für schizophrene patienten und deren angehörige: einfluß von wissen, krankheitskonzept und expressed emotions (PIP-studie). In Neuere entwicklungen in der behandlung schizophrener psychosen. Edited by Bender W, Hubmann W, Mohr F. VTS-Verlag, München-Haar; 1995.
• [23]Rummel-Kluge C, Pitschel-Walz G, Bauml J, Kissling W: Psychoeducation in schizophrenia–results of a survey of all psychiatric institutions in Germany, Austria, and Switzerland. Schizophr Bull 2006, 32:765-775.
• [24]Rummel-Kluge C, Kluge M, Kissling W: Frequency and relevance of psychoeducation in psychiatric diagnoses: results of two surveys five years apart in German-speaking European countries. BMC Psychiatry 2013, 13:170. BioMed Central Full Text
• [25]Rummel-Kluge C, Stiegler-Kotzor M, Schwarz C, Hansen W, Kissling W: Peer-counseling in schizophrenia: patients consult patients. Patient Educ Couns 2008, 70:357-362.
• [26]McGill CW, Patterson CJ: Former patients as peer counselors on locked psychiatric inpatient units. Psychiatr Serv 1990, 41:1017-1019.
• [27]Rummel CB, Hansen W, Helbig A, Pitschel-Walz G, Kissling W: Peer-to-peer psychoeducation in schizophrenia: a new approach. J Clin Psychiatry 2005, 66:1580-1585.
• [28]Bäuml J, Pitschel-Walz G: Psychoedukation bei schizophrenen Erkrankungen: Konsensuspapier der Arbeitsgruppe "Psychoedukation bei schizophrenen Erkrankungen". Schattauer, Stuttgart, New York; 2003.
• [29]Froböse T, Bäuml J, Jahn T, Pohl C, Pitschel-Walz G: Knowledge gain by psychoeducation for patients with schizophrenia: associations with sociodemographic data, psychopathology, insight and global neurocognitive performance. Int J Clin Psychiatry Mental Health 2014, 2:111-121.
• [30]Thompson K, Kulkarni J, Sergejew AA: Reliability and validity of a new medication adherence rating scale (MARS) for the psychoses. Schizophr Res 2000, 42:241-247.
• [31]Amador XF, Strauss DH, Yale SA, Flaum MM, Endicott J, Gorman JM: Assessment of insight in psychosis. Am J Psychiatry 1993, 1:873.
• [32]Hays WL: Statistics for the social sciences. 2nd edition. Holt, Rinehart and Winston, New York; 1973.
• [33]Markowitz M, Karve S, Panish J, Candrilli SD, Alphs L: Antipsychotic adherence patterns and health care utilization and costs among patients discharged after a schizophrenia-related hospitalization. BMC Psychiatry 2013, 13:246. BioMed Central Full Text
• [34]McFarlane WR, Dixon L, Lukens E, Lucksted A: Family psychoeducation and schizophrenia: a review of the literature. J Marital Fam Ther 2003, 29:223-245.
• [35]Cohen AN, Glynn SM, Murray-Swank AB, Barrio C, Fischer EP, McCutcheon SJ, et al.: The family forum: directions for the implementation of family psychoeducation for severe mental illness. Psychiatr Serv 2008, 59:40-48.
• [36]Frank F, Rummel-Kluge C, Berger M, Bitzer EM, Holzel LP: Provision of group psychoeducation for relatives of persons in inpatient depression treatment–a cross-sectional survey of acute care hospitals in Germany. BMC Psychiatry 2014, 14:143. BioMed Central Full Text
• [37]Farrelly S, Clement S, Gabbidon J, Jeffery D, Dockery L, Lassman F, et al.: Anticipated and experienced discrimination amongst people with schizophrenia, bipolar disorder and major depressive disorder: a cross sectional study. BMC Psychiatry 2014, 14:157. BioMed Central Full Text
• [38]Hasson-Ohayon I, Avidan-Msika M, Mashiach-Eizenberg M, Kravetz S, Rozencwaig S, Shalev H, et a. Metacognitive and social cognition approaches to understanding the impact of schizophrenia on social quality of life. Psychiatry Research 2012;200(2-3):802–806.
• [39]Hasson-Ohayon I, Ehrlich-Ben Or S, Vahab K, Amiaz R, Weiser M, Roe D: Insight into mental illness and self-stigma: the mediating role of shame proneness. Psychiatry Res 2012, 200:802-806.
• [40]Hasson-Ohayon I, Kravetz S, Roe D, David AS, Weiser M: Insight into psychosis and quality of life. Compr Psychiatry 2006, 47:265-269.